SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending as its community rallies around its meme-driven "infection" narrative, promoting the token's fun and engaging culture. Discussions highlight the strong community and the idea that the "PumpMindVirus" is a universal experience. Participants express bullish sentiment and encourage others to join the $PMV movement, originating from $PUMP on the Solana blockchain.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

CVKD is trending due to a Zacks Small Cap Research report announcing a price target of $30, sparking community discussion about the company's potential. The conversation also includes mentions of the company's recent Frunexian acquisition and a Noble Capital Markets Research Report that highlights product pipeline updates. Some traders are discussing the company's financials, potential dilution, and overall market opportunity within the cardiovascular therapeutics space.

SuperVerse is a unified Web3 ecosystem connecting gaming, DeFi, and AI under a single interoperable protocol. Its native token, $SUPER, powers transactions, governance, and access to immersive games, AI-powered tools, and liquidity infrastructure such as Blackhole DEX. Designed for real utility across multiple chains, $SUPER enables staking, protocol buybacks, and sustainable yield while supporting a growing suite of decentralized applications.

SuperFarm

SuperFarm ($SUPER) is trending amid discussions about potential breakouts and targets, with some community members pointing to a possible Upbit listing announcement as a catalyst. Others suggest that influencers are starting to pump the coin, while some warn of bearish signals and potential downside. The community is actively debating entry points, potential gains, and whether it's too late to buy.

Amplify ETF Trust - Amplify Solana 3% Monthly Option Income ETF

Amplify Solana 3% Monthly Option Income ETF

SOLM is trending as traders analyze the fund's strategy to generate a targeted 3% monthly income through covered calls on Solana. Concerns are emerging about the fund's ability to achieve its high yield target, with some questioning the riskiness and accuracy of its option bets. The community is closely monitoring the fund's holdings and performance to assess its viability.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Starknet is trending as community members highlight the network's recent milestones, including increased staking and adoption, with some drawing comparisons to Zcash due to its privacy features. The conversation is also focused on Starknet's potential to scale Bitcoin through innovative staking mechanisms and its quantum-resistant technology. Overall, there is a sense of growing momentum and confidence in Starknet's ecosystem and future prospects.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending due to a CFO's warning against short-sellers, sparking retail interest and discussions around potential government support. The community is debating the validity of short positions and anticipating news, with some focusing on the company's long-term potential in deep-sea mining. Broader interest in seabed resource exploration, including potential partnerships and regulatory developments, is also fueling the conversation.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

Cel-Sci Corp

Cel-Sci Corp (CVM) is trending due to discussions surrounding the potential FDA approval of Multikine, particularly based on its survival benefits in a Phase 3 subpopulation. Community members are focused on a partnership with Dallah Pharma and its strategic significance in CEL-SCI's overall market strategy, including capital-efficient market entry and revenue generation. Bullish sentiment is fueled by the hope of FDA approval, driving speculation and increased attention on the stock.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad ($MON) is trending as traders discuss its potential as a high-performance EVM-compatible blockchain, with some drawing comparisons to early Ethereum and Solana. Community members are actively debating its market cap potential and whether it can break past the $0.05 resistance level, while others are highlighting the project's decision to refuse Binance's listing terms. Recent whale activity has also spurred conversation, with mega whales and normal whales significantly increasing their holdings.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending due to its growing community and its positioning as a culture-driven token on the Solana blockchain. The community emphasizes positivity, creativity, and freedom of expression, drawing comparisons to Bitcoin but with a unique focus on cannabis culture. Discussions highlight the project's organic growth and welcoming vibe within the crypto space.

Quantum Resistant Ledger is a cryptocurrency based on the Python programming language, aimed at combating future attacks by quantum computers. This cryptocurrency is the brainchild of Peter Waterland who realised that Bitcoin, Ethereum, and other such cryptocurrencies have no protection against future technology. It claims to be a “future-proof” cryptocurrency which enables transactions and decentralized communication while providing protection against classical as well as quantum computer attacks.  The Quantum Resistant Ledger company was founded by Peter Waterland, who found that Bitcoin, as well as Ethereum signatures are susceptible to attacks by powerful quantum computers. His research on quantum computers and signature programs let to the development of this new cryptocurrency, designed to be resistant to the present classical attacks as well as any future quantum computer attacks. Their team is made up of a diverse range of members spread out across the world, including developers (core, blockchain, mobile developers, etc.), analysts, advisors, marketing managers, designers and more.  Quantum Resistant Ledger is the first ever cryptocurrency and the only one in existence as of August 2018, to consider the threat that the future technology of quantum computing poses to cryptocurrencies and their working. It uses a technology specifically designed for post-quantum security, called XMSS, which makes it secure against powerful quantum computers even while using a Proof-of-Stake consensus mechanism. Security against cyber-attacks is a very serious concern in this digital age, especially when you have digital assets whose loss is likely to lead you to bankruptcy.  QRL is the first blockchain technology that provides durability and stability through resistance to quantum computer attacks. The encryption methods used by modern blockchains can become vulnerable to quantum computers over the next ten years. QRL tries to create a blockchain with long-term stability. By using blockchain technology, the QRL platform creates a “ledger” that generates hashes in such a way that it is virtually impenetrable to any type of computer attack.

Quantum Resistant Ledger 

Quantum Resistant Ledger is trending as the community highlights its unique position as a quantum-resistant blockchain, designed to withstand future quantum computing threats. Community members are actively discussing recent quantum computing breakthroughs and IBM's developments, seeing $QRL as a hedge against vulnerabilities in other cryptocurrencies like $BTC and $ETH. Discussions include ease of access through new exchange listings and upcoming airdrops.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$L  
For what it&#39;s worth. &quot;The buyer is Janus Henderson, a large institutional investor with a strong track record in biotech. This comes just before several potential catalysts:
• Additional CIRM grant (California Institute for Regenerative Medicine)
• Milestone payment (from Roche or a partner in the OpRegen program)
• New clinical trial (likely in a new cell therapy area)
4. Signaling Value
• Buying large funds before the catalysts, not after. »

« This type of transaction (a direct placement to a single fund) often indicates prior due diligence—Janus likely had inside access to management and prospects. »

I&#39;m glad the story is going in the right direction… but stay calm :-)

StockTwits for iOS

Loews Corp.

  
For what it's worth. "The buyer is Janus Henderson, a large institutional investor with a strong track record in biotech. This comes just before several potential catalysts:
• Additional CIRM grant (California Institute for Regenerative Medicine)
• Milestone payment (from Roche or a partner in the OpRegen program)
• New clinical trial (likely in a new cell therapy area)
4. Signaling Value
• Buying large funds before the catalysts, not after. »

« This type of transaction (a direct placement to a single fund) often indicates prior due diligence—Janus likely had inside access to management and prospects. »

I'm glad the story is going in the right direction… but stay calm :-)